Literature DB >> 6885820

Insertion of fluorescent phosphatidylserine into the plasma membrane of red blood cells. Recognition by autologous macrophages.

Y Tanaka, A J Schroit.   

Abstract

The interaction of macrophages with red blood cells (RBC) displaying phosphatidylserine (PS) in their surface membranes was investigated after the transfer of an exogenously supplied fluorescent lipid analog to the RBC. Nonfluorescent (quenched) lipid vesicles were formed by ultrasonication from 1-acyl-2-[(N-4-nitro-benzo-2-oxa-1,3 diazole)aminocaproyl]phosphatidyl-serine (NBD-PS) or 1-acyl-2[(N-4-nitrobenzo-2-oxa-1,3 diazole)aminocaproyl]phosphatidylcholine (NBD-PC). The interaction of these vesicles with RBC was monitored as a function of vesicle concentration by assessment of the degree to which cell-associated lipid fluorescence was dequenched after vesicle treatment. When vesicle concentrations of less than 100 ng/ml were used, lipid fluorescence was largely dequenched, indicating that lipid transfer was the predominant mechanism of both NBD-PS and NBD-PC uptake; however, when vesicle concentrations were increased to greater than 100 ng/ml, a concentration-dependent increase in the fraction of quenched cell-associated lipid was observed, indicating that another mechanism, possibly vesicle-cell adhesion, also occurred. Using NBD-PS at concentrations at which dilution of all the phospholipid analog in the recipient cell membrane could be unequivocally confirmed, we observed that the uptake of NBD-PS-treated RBC by macrophages was increased 5-fold over that of controls, whereas the uptake of RBC containing an equivalent amount of exogenously supplied NBD-PC was unaltered. Furthermore, preincubation of macrophage monolayers with vesicles containing PS resulted in a approximately 60% inhibition in the uptake of NBD-PS-treated RBC, whereas no inhibition in the uptake of control, opsonized, or NBD-PC-treated RBC was observed. These findings suggest that PS in the outer leaflet of RBC might serve as a signal for triggering their recognition by macrophages.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6885820

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Macrophages lacking scavenger receptor A show a decrease in binding and uptake of acetylated low-density lipoprotein and of apoptotic thymocytes, but not of oxidatively damaged red blood cells.

Authors:  V Terpstra; N Kondratenko; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

Review 2.  Platelet-derived microparticles and the potential of glycoprotein IIb/IIIa antagonists in treating acute coronary syndrome.

Authors:  Ximing Li; Hongliang Cong
Journal:  Tex Heart Inst J       Date:  2009

Review 3.  Programmed cell death and the immune system.

Authors:  Shigekazu Nagata; Masato Tanaka
Journal:  Nat Rev Immunol       Date:  2017-02-06       Impact factor: 53.106

Review 4.  Transmembrane movements of lipids.

Authors:  A Zachowski; P F Devaux
Journal:  Experientia       Date:  1990-06-15

5.  Oxidized phosphatidylcholines facilitate phospholipid flip-flop in liposomes.

Authors:  Roman Volinsky; Lukasz Cwiklik; Piotr Jurkiewicz; Martin Hof; Pavel Jungwirth; Paavo K J Kinnunen
Journal:  Biophys J       Date:  2011-09-20       Impact factor: 4.033

6.  Phospholipids in inflammatory synovial effusions.

Authors:  L Punzi; S Todesco; G Toffano; R Catena; E Bigon; A Bruni
Journal:  Rheumatol Int       Date:  1986       Impact factor: 2.631

7.  Transbilayer mobility and distribution of red cell phospholipids during storage.

Authors:  D Geldwerth; F A Kuypers; P Bütikofer; M Allary; B H Lubin; P F Devaux
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

8.  Recognition of live phosphatidylserine-labeled tumor cells by dendritic cells: a novel approach to immunotherapy of skin cancer.

Authors:  Michael R Shurin; Alla I Potapovich; Yulia Y Tyurina; Irina L Tourkova; Galina V Shurin; Valerian E Kagan
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

9.  Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients.

Authors:  R H Wang; G Phillips; M E Medof; C Mold
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

10.  Phosphatidylserine as a determinant of reticuloendothelial recognition of liposome models of the erythrocyte surface.

Authors:  T M Allen; P Williamson; R A Schlegel
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.